Optiscan Imaging Ltd - Company Profile
Powered by 
All the sales intelligence you need on Optiscan Imaging Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Optiscan Imaging Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Optiscan Imaging Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Optiscan Imaging Ltd (Optiscan) is a medical technology company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company provides real-time, non-invasive, slide-free digital imaging solutions. The company’s major products include fiber optic fluorescence confocal endomicroscopes, such as ViewnVivo for life sciences research and InVivage for intra-oral applications. These products are used by healthcare professionals and researchers for applications in disease detection, surgical margin assessment, and research in physiology and pathology. The company conducts clinical trials on microimaging in the fields of gastrointestinal endoscopy, and neurosurgery. It has distributors in China, Europe, North America, Asia, and other countries. Optiscan is headquartered in Melbourne, Victoria, Australia.
Optiscan Imaging Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Vivo Imaging Device | Optiscan |
| Miniaturised Fluorescence Endomicroscope | InVue |
| Microscopic Medical Imaging | ViewnVivo |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In November, the company entered into an agreement with Australian Clinical Labs (ACL) to advance the adoption and commercial readiness of the company’s InForm digital pathology platform. |
| 2025 | Contracts/Agreements | In June, the company entered into partnership with Long Grove Pharmaceuticals aimed at transforming cancer detection. |
| 2025 | Contracts/Agreements | In June, the company entered into a collaboration with US-based Long Grove Pharmaceuticals to accelerate FDA submissions and expand clinical applications of its real-time imaging technology. |
Competitor Comparison
| Key Parameters | Optiscan Imaging Ltd | Intuitive Surgical Inc | Sonic Healthcare Ltd | RadNet Inc | Fujifilm VisualSonics Inc |
|---|---|---|---|---|---|
| Headquarters | Australia | United States of America | Australia | United States of America | Canada |
| City | Mulgrave | Sunnyvale | Sydney | Los Angeles | Toronto |
| State/Province | Victoria | California | New South Wales | California | Ontario |
| No. of Employees | 8 | 15,638 | 45,000 | 8,546 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Camile Farah | Chief Executive Officer; Managing Director | Executive Board | 2021 | - |
| Darius Ooi | Chief Financial Officer | Senior Management | 2025 | - |
| Sanchitha Fernando | Chief Technology Officer | Senior Management | 2023 | - |
| Belinda Williamson | Chief Commercial Officer | Senior Management | 2025 | - |
| Robert Cooke | Chairman | Non Executive Board | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer